CN103566302A - Traditional Chinese medicine for treating atrophic gastritis - Google Patents
Traditional Chinese medicine for treating atrophic gastritis Download PDFInfo
- Publication number
- CN103566302A CN103566302A CN201310502197.4A CN201310502197A CN103566302A CN 103566302 A CN103566302 A CN 103566302A CN 201310502197 A CN201310502197 A CN 201310502197A CN 103566302 A CN103566302 A CN 103566302A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- radix
- traditional chinese
- atrophic gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating atrophic gastritis. The traditional Chinese medicine is composed of the following traditional Chinese medicine raw materials by weight: 5-15 g of bupleurum, 5-15 g of dangshen, 10-20 g of lily, 10-20 g of yam, 5-15 g of angelica, 5-15 g of radix curcumae, 5-15 g of radix linderae, 5-15 g of smoked plum, 5-15 g of rubefacient and 3-12 g of licorice. The traditional Chinese medicine provided by the invention adopts the treatment rules of tonifying qi and strengthening mid-energy, promoting blood circulation to remove blood stasis, tonifying stomach and promoting fluid, neutralizing blood and promoting granulation, and a medicine formula is carefully selected to treat both manifestation and root cause of disease. As shown in clinic application verification, the curative effect of the traditional Chinese medicine for treating atrophic gastritis is excellent and reliable, the medicine property is mild, no toxic side effect occurs, the total effective rate is 98%, and the traditional Chinese medicine is simple and convenient to prepare, wide in medicine source and low in cost.
Description
Technical field
The present invention relates to a kind of technical field of Chinese medicines, specifically a kind of Chinese medicine for the treatment of atrophic gastritis.
Background technology
Atrophic gastritis also claims chronic atrophic gastritis, with gastric epithelial and body of gland atrophy, and decreased number, gastric mucosa attenuation, mucosa basic unit thickens, or companion gland metaplasia and intestinal gland metaplasia, or to have atypical hyperplasia be the chronic digestive system disease of feature.Often show as epigastrium dull pain, distension, belch, inappetence, or become thin, anemia etc., without specificity.A kind of many paathogenic factors disease and precancerous lesion.
Atrophic gastritis is many to be developed by chronic superficial gastritis, clinical manifestation be abdominal distention, upper abdominal pain or epigastric discomfort, early full sense, a little polyphagia abdominal distention is more obvious, even there is belch, nauseating, dyspepsia, tired, become thin, poor appetite, the symptoms such as anemia, the clinical manifestation of atrophic gastritis not only lacks specificity, and also not quite identical with lesion degree.Clinically, some Chronic Atrophic Gastritis Patients can non-evident sympton.But Most patients can have epigastrium causalgia, distending pain, dull pain or distension, painful abdominal mass vexed, especially with after eating for very, the symptoms such as inappetence, nauseating, belch, constipation or diarrhoea.Severe patient can be become thin, anemia, onychorrhexis, glossitis or atrophy of tongue papillae, and minority gastric mucosal erosion person can be with upper gastrointestinal hemorrhage.Because primary disease sickness rate is high, and Chang Fanfu outbreak clinically, be difficult for healing, close with being related of gastric cancer again, thereby atrophic gastritis is more and more subject to people's attention.The treatment of atrophy gastritis is mainly adopted protection gastric mucosa, anti-Helicobacter pylori, strengthens gastric motility, and the symptomatic treatment such as pain relieving, its medicine has: gastric mucosal protection medicine, digestant, anti helicobacter pylori medicine etc.Although can obtain certain alleviation by treatment, be difficult to reach thorough healing object.
Summary of the invention
In order to solve the problem of thorough healing atrophic gastritis disease, the invention provides a kind of Chinese medicine for the treatment of atrophic gastritis, through clinical use demonstration, this medicine is relief of symptoms in use not only, and, after use, can thoroughly cure atrophic gastritis, it is not recurred, particular significant effect, has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine for the treatment of atrophic gastritis, it is characterized in that: the medicine of this treatment atrophic gastritis is comprised of the raw material of Chinese medicine of following weight: 5～15 grams of Radix Bupleuri, 5～15 grams of Radix Codonopsis, 10～20 grams of Bulbus Liliies, 10～20 grams of Rhizoma Dioscoreaes, 5～15 grams of Radix Angelicae Sinensis, 5～15 grams of Radix Curcumaes, 5～15 grams of the Radixs Linderae, 5～15 grams of Fructus Mumes, 5～15 grams of Radix Polygoni Ciliinerve, 3～12 grams, Radix Glycyrrhizae.
Optimal technical scheme of the present invention is: 10 grams of Radix Bupleuri, 10 grams of Radix Codonopsis, 15 grams of Bulbus Liliies, 15 grams of Rhizoma Dioscoreaes, 10 grams of Radix Angelicae Sinensis, 10 grams of Radix Curcumaes, 10 grams of the Radixs Linderae, 10 grams of Fructus Mumes, 10 grams of Radix Polygoni Ciliinerve, 7 grams, Radix Glycyrrhizae.
Pharmacology of the present invention is:
Radix Bupleuri: meridian distribution of property and flavor: cold nature, bitter in the mouth, pungent, return Liver Channel, gallbladder meridian, tool depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, loose effect of fire.
Radix Codonopsis: property is flat, sweet in the mouth, micro-acid.Return spleen, lung meridian.Invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
Bulbus Lilii: sweet, flat, nontoxic; Cure mainly pathogen precordial pain and distention of the abdomen, sharp defecation, invigorating the spleen and replenishing QI.Except edema cranium swollen, the interventral accumulated heat distension of breast, whole body pain, newborn tasty laryngopharynx swelling and pain, gulp down a mouthful saliva difficulty, tears only.Except diaphragm portion distending pain, control beriberi heat syndrome cough.Feel at ease, calm the nerves, beneficial will, supports the five internal organs, controls mad palpitation with fear, the warming the lung antitussive of crying of insane heresy.
Rhizoma Dioscoreae: sweet, flat.Strengthening the spleen and stomach, lung benefiting kidney, tonify deficiency are won.Control anorexia and loose stool, asthenia, breath with cough, frequent micturition, leukorrhagia, quench one's thirst.
Radix Angelicae Sinensis: sweet in the mouth; Pungent; Bitter; Warm in nature, return liver; The heart; Spleen channel.Enrich blood; Invigorate blood circulation; Menstruction regulating and pain relieving; Moisturize laxation.
Radix Curcumae: pungent, bitter, cold.Return liver, the heart, lung meridian.Promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
The Radix Linderae: pungent, temperature.Enter stomach, kidney channel, has a respite, warming middle-JIAO, cold expelling, pain relieving.
Fructus Mume: sour, puckery, flat.Return liver, spleen, lung, large intestine channel.Protection the intestines and stomach, astringes the lung, and astringing intestine to stop diarrhea, promotes the production of body fluid, relieving colic caused by ascaris.For chronic cough of deficiency lung; Deficiency-heat excessive thirst; Chronic malaria; Chronic diarrhea; Dysentery; Have blood in stool; Hematuria; Metrorrhagia; Ascariasis of biliary tract stomachache; Vomiting; Ancylostomiasis.
Radix Polygoni Ciliinerve: bitter, be slightly cold and return Liver Channel clearing away heat and cooling blood eliminating stasis to stop pain; Dysentery bacterium, vibrio cholera, staphylococcus are had to inhibitory action.
Radix Glycyrrhizae: sweet in the mouth is flat.Enter spleen, stomach, lung meridian.QI invigorating invigorating middle warmer; Relieving spasm to stop pain; Nourishing the lung to arrest cough; Eliminating fire and detoxication; Coordinating the actions of various ingredients in a prescription.Main asthenia lack of appetite; Leanness yellowish complexion; Shortness of breath and palpitation; Stomachache loose stool; The anxious pain of extremity contraction; Hysteria; Cough and asthma; Laryngopharynx swelling and pain; Carbuncle skin ulcer swells and ache; Infantile carbuncle; And medicine, alimentary toxicosis.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Chinese medicine of the present invention is under Traditional Chinese medical theory and clinical experience instruct, and take QI invigorating warming middle-JIAO, blood circulation promoting and blood stasis dispelling, reinforcing stomach reg fluid and blood granulation promoting is the rule for the treatment of, selected medicament composing prescription, treating both the principal and secondary aspects of a disease.
The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component medicines adopt the use that is decocted in water for oral dose.
The invention has the beneficial effects as follows: the Chinese medicine of this treatment atrophic gastritis, through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and total effective rate reaches 98%.Its preparation is easy, medicine source is wide, cost is low.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine for atrophic gastritis, its raw material of Chinese medicine by following weight forms: 10 grams of Radix Bupleuri, 10 grams of Radix Codonopsis, 15 grams of Bulbus Liliies, 15 grams of Rhizoma Dioscoreaes, 10 grams of Radix Angelicae Sinensis, 10 grams of Radix Curcumaes, 10 grams of the Radixs Linderae, 10 grams of Fructus Mumes, 10 grams of Radix Polygoni Ciliinerve, 7 grams, Radix Glycyrrhizae.
Embodiment 2
Treat a Chinese medicine for atrophic gastritis, its raw material of Chinese medicine by following weight forms: 8 grams of Radix Bupleuri, 8 grams of Radix Codonopsis, 12 grams of Bulbus Liliies, 12 grams of Rhizoma Dioscoreaes, 8 grams of Radix Angelicae Sinensis, 8 grams of Radix Curcumaes, 8 grams of the Radixs Linderae, 8 grams of Fructus Mumes, 8 grams of Radix Polygoni Ciliinerve, 5 grams, Radix Glycyrrhizae.
Embodiment 3
Treat a Chinese medicine for atrophic gastritis, its raw material of Chinese medicine by following weight forms: 12 grams of Radix Bupleuri, 12 grams of Radix Codonopsis, 17 grams of Bulbus Liliies, 17 grams of Rhizoma Dioscoreaes, 12 grams of Radix Angelicae Sinensis, 12 grams of Radix Curcumaes, 12 grams of the Radixs Linderae, 12 grams of Fructus Mumes, 12 grams of Radix Polygoni Ciliinerve, 9 grams, Radix Glycyrrhizae.
Embodiment 4
Treat a Chinese medicine for atrophic gastritis, its raw material of Chinese medicine by following weight forms: 6 grams of Radix Bupleuri, 6 grams of Radix Codonopsis, 10 grams of Bulbus Liliies, 10 grams of Rhizoma Dioscoreaes, 6 grams of Radix Angelicae Sinensis, 6 grams of Radix Curcumaes, 6 grams of the Radixs Linderae, 6 grams of Fructus Mumes, 6 grams of Radix Polygoni Ciliinerve, 4 grams, Radix Glycyrrhizae.
Embodiment 5
Treat a Chinese medicine for atrophic gastritis, its raw material of Chinese medicine by following weight forms: 15 grams of Radix Bupleuri, 15 grams of Radix Codonopsis, 20 grams of Bulbus Liliies, 20 grams of Rhizoma Dioscoreaes, 15 grams of Radix Angelicae Sinensis, 15 grams of Radix Curcumaes, 15 grams of the Radixs Linderae, 15 grams of Fructus Mumes, 15 grams of Radix Polygoni Ciliinerve, 12 grams, Radix Glycyrrhizae.
Chinese medicine in the embodiment of the present invention, its processing technology and Therapeutic Method are: the raw material of Chinese medicine of prescription is mixed mutually, be placed in medicine pot, add clear water and do not have 7 centimetres of powder, soak after 30 minutes, decoct with high heat, after boiling, with slow fire boiling 20 minutes, approximately 350 grams of the filtrates removed slag to obtain were taken after room temperature, potion on the one, 10 doses is a course for the treatment of.Every day, supper was taken after 1 hour, and patient takes 1～2 course for the treatment of, can cure.
Through the clinical practice to 100 routine atrophic gastritis diseases over 1 year, obtained good curative effect, total effective rate reaches 96%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select the projects such as medical history, the state of an illness, age and original therapy method.
2. patient originates: with general hospital patient and special chinic patient in hospital.
3. case enters group standard, according to clinical manifestation and the pathological characters of patients with atrophic gastritis, divides, and 20 years old～65 years old age, more than course of disease January～1 year; Various other of stopping using before treatment treated medicine and the therapeutic modality of atrophic gastritis.
4. administrated method: patient's supper every day is taken the medicinal liquid of decocting after 1 hour, once-a-day, serveing on 10 is a course for the treatment of, and patient takes 1～2 course for the treatment of, can cure.
5. efficacy evaluation:
(1) recovery from illness: clinical symptoms and sign disappear, and appetite is normal;
(2) remarkable: clinical symptoms and sign disappear substantially, appetite is improved;
(3) effective: clinical symptoms and sign obviously alleviate, but still leave over a part of symptom;
(4) invalid: clinical symptoms and sign are slightly improved or without improvement.
6. efficacy analysis:
(1) course of disease: 1 month～2 months 10 examples, 2 months～3 months 35 examples, 3 months are 55 examples above;
(2) age group: 20 years old～30 years old 10 examples, 31 years old～40 years old 40 examples, 41～65 years old 50 example;
(3) disease type and curative effect: see the following form, administration time is 1～2 course for the treatment of.
By Chinese medicine treatment atrophic gastritis of the present invention, received satisfied curative effect.Atrophic gastritis symptom is a lot, before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain good curative effect, especially Western medicine is for oral administration, and side effect is larger, human body is caused to very major injury, and most of sufferers all be can't stand drug withdrawal voluntarily because bearing.
In taking the process of medicine of the present invention, must not take Western medicine and use injection, or the medicine of other treatment atrophic gastritis.
Drug administration of the present invention is without any side effects, evident in efficacy, and its cure rate reaches 98%.
Claims (2)
1. a Chinese medicine for the treatment of atrophic gastritis, it is characterized in that: the raw material of Chinese medicine by following weight forms: 5～15 grams of Radix Bupleuri, 5～15 grams of Radix Codonopsis, 10～20 grams of Bulbus Liliies, 10～20 grams of Rhizoma Dioscoreaes, 5～15 grams of Radix Angelicae Sinensis, 5～15 grams of Radix Curcumaes, 5～15 grams of the Radixs Linderae, 5～15 grams of Fructus Mumes, 5～15 grams of Radix Polygoni Ciliinerve, 3～12 grams, Radix Glycyrrhizae.
2. a kind of Chinese medicine for the treatment of atrophic gastritis according to claim 1, is characterized in that: the raw material of Chinese medicine by following weight forms: 10 grams of Radix Bupleuri, 10 grams of Radix Codonopsis, 15 grams of Bulbus Liliies, 15 grams of Rhizoma Dioscoreaes, 10 grams of Radix Angelicae Sinensis, 10 grams of Radix Curcumaes, 10 grams of the Radixs Linderae, 10 grams of Fructus Mumes, 10 grams of Radix Polygoni Ciliinerve, 7 grams, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310502197.4A CN103566302A (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310502197.4A CN103566302A (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating atrophic gastritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103566302A true CN103566302A (en) | 2014-02-12 |
Family
ID=50039583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310502197.4A Pending CN103566302A (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103566302A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888119A (en) * | 2015-06-10 | 2015-09-09 | 吴光付 | Traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264282A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Chinese medicinal composition for treating chronic atrophic gastritis and preparation thereof |
| CN101791387A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for treating chronic gastritis |
-
2013
- 2013-10-23 CN CN201310502197.4A patent/CN103566302A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264282A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Chinese medicinal composition for treating chronic atrophic gastritis and preparation thereof |
| CN101791387A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for treating chronic gastritis |
Non-Patent Citations (1)
| Title |
|---|
| 慢性萎缩性胃炎;杨景海等;《古今中医效验秘方宝典》;20090131;23 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888119A (en) * | 2015-06-10 | 2015-09-09 | 吴光付 | Traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705843B (en) | A kind of medicine for the treatment of gastropathy | |
| CN102764403B (en) | Traditional Chinese medicine for treating chronic gastritis and gastroduodenal ulcer | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN103301400B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis | |
| CN103341150B (en) | Traditional Chinese medicine preparation for treating chronic gastritis | |
| CN104352920A (en) | Digestion-helping and stomach-conditioning traditional Chinese medicinal composition | |
| CN104288745A (en) | Traditional Chinese medicine for treating CG (Chronic Gastritis) | |
| CN103212020B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN104306888A (en) | Traditional Chinese medicine for treating chronic gastroenteritis | |
| CN103566302A (en) | Traditional Chinese medicine for treating atrophic gastritis | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
| CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
| CN103800638B (en) | A kind of traditional Chinese medicine plaster and preparation method for treating mastosis | |
| CN102961662B (en) | Medicine for treating gastric ulcer and preparation method thereof | |
| CN106266107A (en) | A kind of Chinese medicine composition treating sucutaneous nodule goiter and preparation method thereof | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN106236873A (en) | A kind of Chinese medicine composition treating disease of stomach | |
| CN106214977A (en) | A kind of treat dysphagic Chinese medicine composition | |
| CN104758620A (en) | Liver-soothing and bladder-relieving agent for patients with cholecystitis and preparation method of liver-soothing and bladder-relieving agent | |
| CN105999060A (en) | Traditional Chinese medicine composition for treating blood stasis type of female abdominal mass and preparation method thereof | |
| CN105497818A (en) | Traditional Chinese medicine preparation for treating rheumatic heart disease | |
| CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN104984305B (en) | A kind of Chinese medicine composition for treating chronic cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140212 |
|
| WD01 | Invention patent application deemed withdrawn after publication |